The lucrative weight-loss drug market won't remain a duopoly eternally. With billions at stake, that ...
Good morning! Eli Lilly, Novo Nordisk and other pharmaceutical corporations presented encouraging data on weight-loss ...
Eli Lilly announced on Friday that it has applied for U.S. approval of its weight-loss ...
The rapidly increasing demand for a category of weight reduction and diabetes drugs has Eli ...
Eli Lilly announced on Friday that the corporate has invested an extra $5.3 billion in ...
Good day! An extremely popular group of weight reduction and diabetes medications continues to be ...
Amgen's shares rose greater than 12% on Friday after the drugmaker reported positive early data ...